Gimon de Graaf

Gimon de Graaf is a Research Fellow at the Erasmus School of Health Policy & Management, specializing in Health Technology Assessment (HTA). His work focuses on economic evaluations in healthcare, particularly for diabetes management, cardiovascular devices, and translational research. He has contributed to systematic reviews and network meta-analyses on self-management interventions and patient outcomes.

Research Trends: His recent publications emphasize cost-effectiveness analyses for remote monitoring technologies, diabetes care innovations, and biomarker translation. Key methodologies include network meta-analysis and multi-criteria decision analysis.

• 2024: REMOTE-CIED study on implantable cardiac defibrillator monitoring.
• 2023: COMPAR-EU recommendations for diabetes self-management interventions.
• 2019: Early economic evaluation frameworks for biomarkers in type 2 diabetes.

Collaborations: He works with European institutions on projects like the EIP on Active and Healthy Ageing and BeNeLuxA pharmaceutical horizon scanning.